GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » MPX International Corp (XCNQ:MPXI) » Definitions » Notes Receivable

MPX International (XCNQ:MPXI) Notes Receivable : C$0.00 Mil (As of Mar. 2022)


View and export this data going back to 2019. Start your Free Trial

What is MPX International Notes Receivable?

MPX International's Notes Receivable for the quarter that ended in Mar. 2022 was C$0.00 Mil.


MPX International Notes Receivable Historical Data

The historical data trend for MPX International's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MPX International Notes Receivable Chart

MPX International Annual Data
Trend Sep18 Sep19 Sep20 Sep21
Notes Receivable
- - - -

MPX International Quarterly Data
Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

MPX International Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.


MPX International Notes Receivable Related Terms

Thank you for viewing the detailed overview of MPX International's Notes Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


MPX International (XCNQ:MPXI) Business Description

Traded in Other Exchanges
N/A
Address
5255 Yonge Street, Suite 701, Toronto, ON, CAN, M2N 6P4
MPX International Corp is a diversified cannabis company focused on developing and operating assets across the global medical and adult use and engaged in cultivating, manufacturing and marketing products that include cannabinoids as their primary active ingredient. The firm is organized into three segments: Canada, Europe/Africa, and Asia-Pacific. The Canada operating segment's principal business activities consist of production and sale of cannabis, video learning and engagement, patient counselling and referral services. The Europe/Africa operating segment's consist of the production and sale of cannabis and hemp-related products. The Asia-Pacific consist of the production and sale of cannabis. The majority of the revenue is generated in Canada.
Executives
William Scott Boyes Director, Senior Officer
Randall Glenn Stafford Director

MPX International (XCNQ:MPXI) Headlines

No Headlines